Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

Oral oncolytics offer a host of benefits for both patients and providers, but cancer programs need to be equipped to properly manage and monitor patients who are self-administering their treatments at home. About This Project WHITE PAPER Read the white paper, Steps to Success: Implementing Oral Oncolytics from ACCC Member Programs, for effective practices, peer-to-peer insight, tools, and …
ACCC’s partner organization, the Cancer Support Community® (CSC) is a nonprofit organization that provides personalized and essential services to those living with cancer and their caregivers including support groups, educational workshops, exercise, art and nutrition classes, and social activities. CSC created the Cancer Experience Registry® to identify and advance the understanding of the emotional …
ACCC-comments-to-CMS-CY-2018-QPP-proposed-rule
OCM-Update
1-ACCC-OCM-Workshop-2017-D'Amato
4-ACCC-OCM-Workshop-2017-Longfellow
System Membership Benefits One free registration to an ACCC national meeting (value $675) every year A discount on the Cancer Program membership rate for each ACCC-member hospital within the system A page on the ACCC website with links to all hospitals in the system that are ACCC Cancer Program Members Subscription to ACCC’s journal Oncology Issues ACCConnect biweekly enewsletter …
Mary DeRome, MSc, is the director of medical communications and education at the Multiple Myeloma Research Foundation (MMRF) in Norwalk, Connecticut where she plans and oversees all MMRF patient and professional education initiatives. Prior to her current position, Ms. DeRome spent twelve years as a senior investigator in small molecule oncology drug discovery at Bayer HealthCare in West Haven, …
Supportive oncology care is essential in management of all cancers, recommended in guidelines, and required by accreditation bodies, such as Commission on Cancer. However, significant barriers—including insufficient fee-for-serve reimbursement and the lack of relevant specialists and staff to deliver these services—prevent consistent availability and delivery of supportive oncology services. ACCC …
Our Supporter This project is sponsored by Amgen
Andrea Conners is the executive director of the Patient Empowerment Network (PEN). Prior to joining PEN, she was the head of U.S. consulting for pharmaphorum connect and head of external R&D communications at AstraZeneca. That role marked the culmination of nearly 10 years in global communications at AstraZeneca in the U.S. and U.K. Before that, Conners held corporate communication roles of increasing …
Step therapy, also known as “fail first” therapy, is not a new concept in healthcare. Originally introduced into the care process by health insurance plans, step therapy was aimed at lowering costs, improving quality of life, and ensuring that patients received the most preferred therapy. The process requires prior authorization by a patient’s health insurer to determine if the patient’s plan will …
Dr. Koffman is a well-known doctor, educator, and clinical professor-turned-patient who has dedicated himself to teaching and helping the CLL community since his own CLL diagnosis in 2005. Dr. Koffman believes that his dual roles as a retired physician and patient give him a unique understanding that allows him to provide clear explanations of complex issues, advocate for his fellow patients, and inform …
Our Supporters This project is sponsored by Johnson & Johnson .
Andrea Conners is the executive director of the Patient Empowerment Network (PEN). Prior to joining PEN, she was the head of U.S. consulting for pharmaphorum connect and head of external R&D communications at AstraZeneca. That role marked the culmination of nearly 10 years in global communications at AstraZeneca in the U.S. and U.K. Before that, Conners held corporate communication roles of increasing …
Jointly Provided By: Supporter This activity is supported by an education grant from Eisai, EMD Serono, Pfizer.
Mary DeRome, MSc, is the director of medical communications and education at the Multiple Myeloma Research Foundation (MMRF) in Norwalk, Connecticut where she plans and oversees all MMRF patient and professional education initiatives. Prior to her current position, Ms. DeRome spent twelve years as a senior investigator in small molecule oncology drug discovery at Bayer HealthCare in West Haven, …
Meredith Barnhart, PhD, LCSW-R, OSW-C, is the director of the Information Resource Center at The Leukemia & Lymphoma Society (LLS). In her role, Dr. Barnhart oversees a team of information specialists who field inquiries from blood cancer patients and their loved ones. She and her team provide comprehensive, personalized, and up-to-date information on the blood cancers, treatment options that can …
Samantha R. Guild, JD, is the director of education, public policy, and patient services for AIM at Melanoma—the largest international melanoma foundation globally engaged and locally invested in advancing the battle against melanoma through innovative research, legislative reform, education, and patient and caregiver support. Ms. Guild is responsible for the development and implementation of AIM’s …
In 2019 ACCC launched a national Comprehensive Cancer Care Services Survey, outcomes of which were used to develop this tiered matrix of recommendations that cancer practices and programs of varying sizes and resource levels can use to benchmark and advocate for service line growth. Provision of these key services can elevate patient care and the patient experience; reduce healthcare costs; improve …